difference between semiglutide and tirzepatide vs. Semaglutide: What You Should Know We know about the growing

The common challenge often discussed in the media is the potential for GLP-1 weight regain risk

Interestingly, the benign insulinomas overexpressed GLP-1 receptors and the administration of a GLP-1 agonist provoked this hypoglycemia

doi: 10.1161/CIRCULATIONAHA.124.067676

The STEP trial program showed that patients receiving semaglutide lost an average of 1215% of body weight over 68 weeks, with some individuals achieving weight reductions exceeding 20%

Physical activity is particularly crucial, as it helps preserve lean muscle mass, increases metabolic rate, and provides psychological benefits that support long-term adherence